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Introduction
Chronic granulomatous disease (CGD) is an inherited
immunodeficiency disorder which results from mal-
function of the NADPH oxidase system in phagocytic
cells. Deficiency of this oxidase, responsible for produc-
tion of microbicidal oxygen metabolites (e.g. super-
oxide), leads to reduced killing of catalase-positive
bacteria (especially staphylococci) and fungi, and
renders affected patients susceptible to recurrent pyo-
genic infections [1,2]. Granuloma formation is induced
by unresolved local bacteria containing foci. Sixty per
cent of CGD is inherited as a sex-linked trait due
to mutations in the gp 91 phox gene which resides at
Xp 21.1. An autosomal recessive inheritance is less
frequent [3].
Clinical manifestations start in 80% before the
second birthday [4] and consist of recurrent pyodermia,
suppurative lymphadenitis, pneumonia, enteritis, liver
abscess, osteomyelitis, and failure to thrive. Aspergillus
pneumonia is the leading cause of death [5]. Under
continuous prophylaxis using intracellularly active
antimicrobials the survival rate at age 20 has increased
to 50% [4]. This report describes a boy with CGD
with an unusual systemic and renal complication,
namely lupus erythematosus with diffuse proliferative
glomerulonephritis.
Case report
The patient (GD) is the first of two children of non-
consanguineous parents. The mother is prone to infec-
tions and, as demonstrated by various leukocyte tests
(Table 1), is a carrier of the disease, like the sister.
The father is healthy. From the age of 10 weeks the
patient developed recurrent episodes of enteritis, cer-
vical and inguinal lymphadenitis, otitis, and pneumo-
nia. Studies of the humoral immune system did not
show any abnormalities. At 12 months of age testing
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of peripheral polymorphonuclear neutrophil cells
(PMN) revealed a severe deficiency of superoxide
anion production, no staining of PMN exposed to
nitroblue tetrazolium, and a reduced cytochrome b
concentration (Table 1). RFLP analysis showed a
mutation at Xp 21.1 (gp 91 phox). However, the
precise molecular genetic mechanism still remains
unclear. After diagnosis of CGD, prophylaxis with
co-trimoxazole and after an additional year with itra-
conazol was instituted, which reduced the rate of
infections. Nevertheless at the age of 3.7 years a severe
Candida pneumonia occurred. Incisor teeth were
extracted because of severe caries.
In December 1993 at the age of 5.5 years routine
examination revealed slight proteinuria and microhae-
maturia. Some weeks later severe oedema of the eyelids,
hands, and ankles, a butterfly rash, and a discrete
maculopapular exanthema on the upper and lower
extremities developed. On admission in February 1994
we additionally observed reduced motility and ten-
derness of the right hip, knees, fingers, and ankles.
Weight was 20.4 kg, height 123 cm, and blood pressure
110/70 mmHg. Cervical and submandibular lymph
nodes were increased in size but acute infection was
absent. Ultrasound examination revealed hepatosplen-
omegaly and both kidneys appeared large (volume
>97th centile) and hyperechogenic. Chest X-ray
showed slight interstitial pulmonary infiltration, and
echocardiography some thickening of the pericardium.
Cranial CT scan was normal.
Laboratory findings
Blood. Hb 9.2g/dl, leukocytes 4500/ul, CD4/CD8
ratio 0.55 (normal 1-1.4), platelets 40000-100 000/ul,
creatinine 0.5 mg/dl, urea 31 mg/dl, total proteins 5.6
decreasing to 4.7 g/dl, albumin 32 decreasing to 23 g/dl,
IgA, IgM, and IgG normal, cholesterol 215-345 mg/dl,
electrolytes, transaminases and coagulation factors
normal.
Serological findings. ANA 1:320 (normal < 1:40),
ds-DNA (ELISA) 2154IU/ml (normal<40 IU/ml),
ssDNA 98% (normal <20%), ENA (nRNP, SSB)
positive, ANCA normal. Functional tests of com-
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Table 1.
Subject
Patient
Mother
Father
Function tests of peripheral polymorphonuclear
Of production
(nmol/10 exp 6 PMN/min)
0.031
7.640
14.210
neutrophils (PMN)
NBT test
(%positive cells)
0
88
100
Cytochrome b
(pmol/10exp6PMN)
0.16
4.30
5.80
FACS
(%positive cells)
2.94
86.50
99.16
NBT, nitroblue tetrazolium; FACS, fluorescence-activated cell scan
plement: classical pathway 20%, alternative pathway
<20% (normal 80-120%, haemolytic titration assay),
C3 0.34mg/ml (normal 0.5-0.9), C4 0.04mg/ml
(normal 0.1-0.4), C3 Nef negative. Cardiolipin
35 U/ml (normal <25). Viral and fungal antibodies
within normal ranges.
Urine. Proteinuria 3.7-6.3 g/m2/24 h (Coumassie
method), SDS-PAGE 93% albumin, 2% low-
molecular, 5% high-molecular proteins, erythrocytes
up to >500/ul, leukocytes 25-60/ul, creatinine clear-
ance 88 ml/min/1.73 m2.
Renal biopsy. Diffuse proliferative glomerulo-
nephritis was found in 25 glomeruli with glomerular
basement membrane thickening and segmental suben-
dothelial deposits (MPGN-like). PAS staining demon-
strated occasional adhesions and immunofluorescence
granular deposits of IgA, IgG, IgM, C3, and C3d in
the mesangium and along glomerular basement mem-
branes in subendothelial and subepithelial locations.
Clinical course
The patient was treated with prednisone 60 mg/m2/day
for 7 weeks followed by decreasing doses on alternate
days (Figure 1). In addition, he received frusemide,
nifedipine, and atenolol because of rising blood pres-
sure. Antibiotic prophylaxis was continued with rifam-
picin (15 mg/kg/day), itraconazole (5-10 mg/kg/day)
and colistin (3 x 106 U/day). The peripheral oedema
and the other clinical symptoms disappeared within a
few weeks, the general state improved, and somatic
development remained normal. Intercurrent otitis
media and lymphadenitis were successfully treated with
ampicillin and cefuroxime. Two episodes of upper
airway infection subsided spontaneously. No clinical
or serological signs of fungal infection appeared.
After 8 months of steroid treatment proteinuria
decreased to 0.3-0.9 g/m2/day and serum albumin
levels rose to 4.2 g/1. Renal function remained normal
(serum creatinine 0.3 mg/dl, urea 22 mg/dl, creatinine
clearance 166 ml/min/1.73 m2); Hb increased to
13.2 g/dl, ANA titres decreased to 1:80 and ds-DNA
to 282 IU/ml.
Discussion
Involvement of the urinary tract has been reported in
38% of patients with CGD. It consists mainly of
urinary tract infections and obstructions due to granu-
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Fig. 1. Course of proteinuria (g/m2 body surface/day), serum
albumin (g/1) and double-stranded (ds) DNA 1 month before and
during 8 months on prednisone therapy. • Daily D Every other day.
loma formation, eventually leading to strictures and
renal abscesses [6]. In contrast, glomerular lesions
have been described in only six cases of CGD aged
3-18 years [6-10]. The initial features were usually
mild, consisting of proteinuria and microscopic haem-
aturia. Renal function was decreased in four cases;
two patients required haemodialysis. Our patient is the
only one who developed overt nephrotic syndrome
with oedema. One further patient reported by Manzi
et al. [10] exhibited a similar clinical course, also
associated with signs and symptoms of SLE.
SLE is a rare disease in small children. According
to Cameron et al. only 130 children below age 10 with
SLE have been reported in the literature; 80% of them
initially presented with renal symptoms and 50%
developed nephrotic syndrome. Under treatment with
corticosteroids and cytotoxic agents the survival rate
in this age group has improved to 85% after 10
years [11].
Manifestations of lupus have repeatedly been noted
in the family history of CGD patients. Therefore the
association of SLE and CGD appears to be causally
related. According to Manzi et al. [10], 22 female
P, proteinuria (g/d); Hm, haematuria, microscopic; SCR, serum creatinine (mg/dl); GFR, glomerular filtration rate (ml/min); NS, nephrotic syndrome; GN, glomerulonephritis; ERSD, end-
stage renal disease; d, day, I.F., imunofluorescence.
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Table 2. Patients with chronic granulomatous disease and glomerulonephritis
Authors Age (years), Symptoms
sex
Renal function Renal biopsy findings Treatment Outcome
van Rhenen et al. 17, f
1987 [7]
Cottin el al. 1982 [8] 5.5, m
Frifelt et al. 1985 [9] 12, m
Manzi el al. 1992 [10] 3, m
McClellan et al. 1992 18, m
[6]
This case 5.5 m
Subcutaneous abscess
P 2.1 g/1, Hm
P0.3
Bladder granuloma
P 1.1, Hm
Rapid deterioration
anuria (6d)
SCR 1.1
GFR60
ESRD at 16 years
SLE, P 2.8
Serum-albumin!
Hm, low C3
dsDNA 1:600
Liver abscess
SLE with NS
SCR 0.4
SCRj
SCR 0.5
Focal GN (advanced sclerosis,
crescents) interstitial fibrosis
Extramembranous GN with
IgG, IgM, Cl deposits
At 14 years: focal segmenta!
glomerulosclerosis, tubular
atrophy. Autopsy:
granulomas in kidney and
other organs
Diffuse membranous changes
focal proliferative GN
segmental necrotizing, I.F.:
IgG, IgM, C3, Clq-deposits
'Immune complex GN'
Diffuse proliferative GN, IF:
IgA, IgG, IgM, C3, Cid
Haemodialysis (210 d)
drainage of abscess
Rifampicin, sulphafurazol,
co-trimoxazole
Haemodialysis, prednisone,
cyclophosphamide, cyclo-
sporin A, amphotericin B
Prednisone 30 mg/48 h
initially, followed by further
immunosuppressive agents
Drainage of Staph. mireus
abscess, antibiotics
Steroids, rifampicin,
itraconazol
Recovery of renal function
At 10 years
P 0.2 g/1, GFR 35
Aspergillus sepsis
Lung infiltration, Aspergillus
sepsis, death at 17 years
SCR 0.9, SLE, controlled
severe Aspergillus infection
Recovery of renal function
SCR 0.3
P 0.3-0.9 g/m2/d
a.
8
CO
a
a.
C/3
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carriers of CGD had clinical features consistent with
lupus-like lesions, such as discoid lupus, photosensitiv-
ity, or aphthous stomatitis. The serological findings in
these carriers were negative with two exceptions: one
with discoid lupus and positive ANA-titres [12] and
one with clinical symptoms of SLE but without renal
manifestations [13]. In another carrier transient glom-
erulonephritis was noted during childhood [14]. In
addition, four CGD patients were reported to have
discoid lupus without dsDNA antibodies [15-17].
The pathoanatomical features observed in the six
cases of CGD reported with glomerular lesions were
variable (Table 2). Besides focal proliferative and
sclerotic lesions, diffuse glomerular involvement was
observed as in our case. Granulomas of the kidney
were noted in only one case [9], Other forms of renal
granulomatous disease seem to be excluded. The
presence of diffuse immunoglobulin and complement
deposits in kidney or skin biopsies [6,7,10] suggests an
immune-complex nephritis. This is supported by rising
titres of circulating immune complexes, as were found
in another patient [8].
The association of CGD with glomerular lesions
and SLE may be the result of an exaggerated inflam-
matory response observed in this disorder. Due to the
defective phagocytes, microbial persistence may lead
to chronic antigen stimulation of the immune system.
Studies by Sato et al. [18] in renal biopsies of patients
with IgA nephropathy suggest that phagocytic dysfunc-
tion of PMN may cause mesangial deposition of
immune complexes. The repeated exposure to antigens
from damaged host cells in CGD could result in over-
production of autoantibodies. In addition, impaired
clearance of antigens or soluble immune complexes
due to overload of the reticuloendothelial system might
cause renal damage. The development of autoimmune
phenomena including SLE also occurs with other her-
editary defects of host defence mechanisms or from
acquired immune deficiency syndromes [19-21]. Our
hypothesis is supported by animal experiments that
showed immune complexes binding to glomerular cells,
stimulating superoxide release [22].
The outcome of CGD patients associated with glom-
erulonephritis varied (Table 2). The case described by
van Rhenen et al. [7] deteriorated rapidly and reached
end-stage renal disease within 4 months but recovered,
at least partly, after 7 months on dialysis treatment. A
partial recovery was also reported in the other cases
except in that of Frifelt et al. [9] who died after 15
months on dialysis. The immunosuppressive treatment
applied in that case was repeatedly followed by pul-
monary infiltrations due to Aspergillus sepsis and was
therefore discontinued. The case reported by Manzi
et al. [10], also associated with SLE, was treated with
steroids and showed a prolonged course, complicated
by multiple Aspergillus and other infections involving
the CNS; for the last 4 years this patient was without
signs of SLE and the proteinuria seems to be well
controlled without immunosuppressive therapy (per-
sonal communication A. H. Urbach).
We were encouraged to use steroids because their
C. P. Schmitt et al.
administration was successful and well tolerated in
CGD patients with obstructions of the gastrointestinal
or urinary tract secondary to persistent granuloma
formation. However, medication has been given in
lower doses and for limited time [6,23]. In our case
steroid treatment was well tolerated and induced a
clinical and serological remission of SLE and renal
symptoms, with a decline of proteinuria below
1 g/m2/day and stable GFR. The mild course of inter-
current infections we observed during steroid therapy
may be ascribed to the relatively high number of
residual cytochrome-b-positive PMN in our patient
(3% versus none in most cases of X-linked CGD).
Lifelong chemoprophylaxis against infections seems to
be important for the outcome [2]. Rifampicin was
chosen because co-trimoxazole had previously induced
thrombocytopenia; in addition, it may be a potential
cause of discoid lupus. Itraconazol was added as a
potent oral antifungal agent which is also active against
Aspergillus. In a recent prospective randomized trial
interferon gamma was found to reduce the frequency
of severe infections [25,26]. This drug was avoided
because of its risk of inducing SLE [27] and previous
applications in our case provoked fever.
In conclusion CGD must be regarded as a potential
cause of chronic glomerulonephritis. Children and
young adults with repeated purulent infections who
present with unexplained proteinuria should be
screened for this disorder. The combination of CGD
with SLE reported here strongly suggests an immune
pathogenesis. An optimal treatment schedule needs to
be worked out for similar cases.
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